Inventor · disambiguated record
Maria Bobadilla
Also filed as: BOBADILLA MARIA
3 granted patents·5 pending applications·1 citations·filing 2004–2023
50Inventor score
Files withBOBADILLA MARIA2CELLESTIA BIOTECH AG1FUNDACION CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOSIII1FUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III1FUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III F S1
Top patents by PatentIndex Score
8 records- 0166US2024075109A1Telomerase reverse transcriptase-based therapiesFUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III·Filed 2023·Application pending·0 cites
- 0259US10274502B2Biomarkers and methods for progression prediction for chronic kidney diseaseUNIV MICHIGAN REGENTS·Filed 2014·Granted Apr 30, 2019·1 cites·6 claims
- 0357US2021260169A1Telomerase reverse transcriptase-based therapiesFUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III F S·Filed 2021·Application pending·0 cites
- 0446US2023338347A1New Use of Inhibitors of the Notch Signalling PathwayCELLESTIA BIOTECH AG·Filed 2021·Application pending·0 cites
- 0545US2007099828A1Biomarkers for the efficacy of calcitonin and parathyroid hormone treatmentBOBADILLA MARIA·Filed 2004·Application pending·0 cites
- 0644US11529396B2Telomerase reverse transcriptase-based therapiesFUNDACION DEL SECTOR PUBLICO ESTATAL CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III F S P CNIO·Filed 2015·Granted Dec 20, 2022·0 cites·7 claims
- 0727US11261434B2Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarctionFUNDACION CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOSIII·Filed 2015·Granted Mar 1, 2022·0 cites·12 claims
- 0818US2012164639A1Methods for detecting low grade inflammationBOBADILLA MARIA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maria Bobadilla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →